Overview
- 38 inspections across 35 sites are on record.
- 90 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-05-21.
At a glance
Inspections
38
Sites
35
Observations
90
Career since
Aug 2020
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| EMSL Analytical, Inc. DBA MPL Laboratories | 21 May 2026 | Human Drugs | On file |
| Novel Laboratories, Inc. d.b.a Lupin Somerset | 17 Apr 2026 | Human Drugs | On file |
| New Life Pharma LLC | 13 Feb 2026 | Human Drugs | On file |
| Wyeth Pharmaceutical Division of Wyeth Holdings LLC | 17 Dec 2025 | Human Drugs | On file |
| Leading Edge Innovations, LLC | 4 Nov 2025 | Human Drugs | On file |
Sites inspected
EMSL Analytical, Inc. DBA MPL LaboratoriesSparta, United States1 insp.
Novel Laboratories, Inc. d.b.a Lupin SomersetSomerset, United States1 insp.
New Life Pharma LLCNorthvale, United States1 insp.
Wyeth Pharmaceutical Division of Wyeth Holdings LLCPearl River, United States1 insp.
Leading Edge Innovations, LLCBranchburg, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Jenny Sung5 shared
Annet R Rajan4 shared
Guerlain Ulysse4 shared
Stephenie M Ortiz3 shared
Monika Borkowska3 shared
Emmanuel T Donyina2 shared
Alisha B Patel2 shared
Amatul H Marium2 shared
Jessica S Estriplet2 shared
Robin P Mathew2 shared
Full investigator report
Get the verbatim findings behind Anthony J Donato's 90 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site